Joel Gozlan
Overview
Explore the profile of Joel Gozlan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calin R, Perillaud-Dubois C, Marot S, Kerrou K, Peytavin G, Bachir M, et al.
Emerg Infect Dis
. 2024 Oct;
30(11):2445-2447.
PMID: 39447209
We report a case of persistent disseminated mpox evolving over >6 months in an HIV/hepatitis B virus co-infected patient in France who had <200 CD4+ cells/mm, pulmonary and hepatic necrotic...
2.
Fofana D, Coulibaly T, Maiga M, Nguyen T, Gozlan J, Diarra Z, et al.
J Virol Methods
. 2024 Sep;
330():115026.
PMID: 39233060
Due to shared routes of transmission, including sexual contact and vertical transmission, HIV-HBV co-infection is common, particularly in sub-Saharan Africa. Measurement of viral load (VL), for both HIV and HBV,...
3.
Gozlan J, Baron A, Boyd A, Salmona M, Fofana D, Minier M, et al.
Life (Basel)
. 2024 Jul;
14(7).
PMID: 39063546
Background: After the global COVID-19 crisis, understanding post-infectious immunity and vaccine efficacy remains crucial. This study aims to assess anti-SARS-CoV-2 immunity through a quantitative analysis of anti-receptor-binding domain (RBD) antibodies...
4.
Lacombe K, Moh R, Chazallon C, Lemoine M, Sylla B, Fadiga F, et al.
Sci Rep
. 2024 May;
14(1):10244.
PMID: 38702350
Access to Hepatis C treatment in Sub-Saharan Africa is a clinical, public health and ethical concern. The multi-country open-label trial TAC ANRS 12311 allowed assessing the feasibility, safety, efficacy of...
5.
Fofana D, Somboro A, Maiga M, Kampo M, Diakite B, Cissoko Y, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(5).
PMID: 36901164
While Hepatitis B virus (HBV) and the human immunodeficiency virus (HIV) are endemic in West Africa, the prevalence of HBV/HIV coinfection and their associated risk factors in children remains unclear....
6.
Marot S, Fofana D, Flandre P, Malet I, Zafilaza K, Leducq V, et al.
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556429
The SARS-CoV-2 neutralizing antibodies response is the best indicator of effective protection after infection and/or vaccination, but its evaluation requires tedious cell-based experiments using an infectious virus. We analyzed, in...
7.
Otiniano A, Van de Wyngaert Z, Brissot E, Dulery R, Gozlan J, Daguenel A, et al.
Bone Marrow Transplant
. 2022 Dec;
58(3):340-342.
PMID: 36481838
No abstract available.
8.
Schnuriger A, Vimont S, Godmer A, Gozlan J, Gallah S, Mace M, et al.
Microbiol Spectr
. 2022 Apr;
10(2):e0277421.
PMID: 35404096
Meningitis/encephalitis (ME) syndromic diagnostic assays can be applied for the rapid one-step detection of the most common pathogens in cerebrospinal fluid (CSF). However, the comprehensive performance of multiplex assays is...
9.
Borde C, Quignon F, Amiel C, Gozlan J, Marechal V, Brissot E
Clin Epigenetics
. 2022 Mar;
14(1):33.
PMID: 35246247
Epstein-Barr virus DNA viral load is used as a surrogate marker to start Rituximab in transplant recipients at risk of developing PTLD. However, an elevated EBV DNAemia does not discriminate...
10.
Paccoud O, Alain S, Gozlan J, Jarboui S, Boutolleau D, Hantz S, et al.
Curr Res Transl Med
. 2022 Jan;
70(2):103329.
PMID: 35021130
No abstract available.